Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Dianthus Therapeutics Q4 EPS $(0.71) Beats $(1.01) Estimate, Sales $457.00K Beat $310.00K Estimate

Author: Happy Mohamed | March 21, 2024 04:03pm
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(1.01) by 29.7 percent. The company reported quarterly sales of $457.00 thousand which beat the analyst consensus estimate of $310.00 thousand by 47.42 percent.

Posted In: DNTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist